NANOBIOTIX Announces First Patient Injected with NBTXR3 in Pancreatic Cancer and Safe to Proceed Notifications for Two Additional Trials From U.S. FDA

Two Additional Phase I Studies in Lung and Esophageal Cancer Pending

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *